HIV prevention in the world of work in sub-Saharan Africa: research and practice

Unlike some diseases that affect the vulnerable (such as children), HIV primarily affects those most productive in the population. Within this context the private sector has a considerable role to play in managing HIV and AIDS and in contributing to comprehensive national responses. As the HIV epidemic expanded in sub-Saharan Africa, it threatened to weaken an already fragile skills base in many countries, placing pressure on worker recruitment and replacement costs, aggravating absenteeism, and contributing to the direct and indirect costs of production and performance (International Finance Corporation, 2002; Ellis & Terwin, 2005; Global Business Coalition on HIV/AIDS & Booz Allen Hamilton, 2006). In South Africa, amid debate over the motivations of company responses to the HIV epidemic and in a context of inaction and denial by the government, large firms took the lead in the provision of antiretroviral therapy (ART) to all employees with HIV who qualified for treatment; they did so well before the South African public health sector made the treatment available in 2004 (Dickinson, 2004). Debswana Diamond Company (De Beers’s operation in Botswana) led this initiative in 2001, followed by Anglo American in 2002 (The Economist, 2002; Van der Walt, 2007). Since then, many corporate firms on the continent have developed well-established programmatic responses to HIV and AIDS (Family Health International, 2002; Dickinson, 2009). National business coalitions have also played a major role in responding to HIV epidemics in sub-Saharan Africa by facilitating the development of workplace policies and programmes, establishing public–private and community partnerships, and generating dialogue between sectors, with businesses providing in-kind contributions and donations (UNAIDS, 2011a). Against this backdrop, company efforts to address HIV in the workplace have been at the forefront of the global response (Sprague & Dickinson, 2008). The need to document and replicate successful HIV/AIDS responses has been repeatedly stressed by all stakeholders. Indeed, national strategic plans in African countries prioritise the dissemination of a growing body of experience and innovation in HIV-related care, treatment and support strategies, across public, private and non-profit sectors (see Government of Botswana, 2003; Government of Lesotho, 2007; Government of South Africa, 2007; Government of Uganda, 2007). While a range of HIV/AIDS-related activities takes place in the world of work in African countries every day, gaps in our knowledge remain. Since 2004, African researchers have come together to create a platform for high-quality applied research on HIV in the workplace, among academics, business people and other interested partners. The aim has been to build on and formalise the network of researchers, particularly new and younger researchers; to signal the importance of supporting university-based research on HIV in the world of work; to conduct quality, evidence-based research on this topic; to inform workplace policies and practices; and, to disseminate the findings of research among other researchers and decision-makers responsible for addressing HIV and AIDS in their organisations. To this end, the South

[1]  T. Lancet HIV treatment as prevention—it works , 2011, The Lancet.

[2]  Lynn Morris,et al.  Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.

[3]  R. Jewkes,et al.  Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study , 2010, The Lancet.

[4]  C. Beyrer Global prevention of HIV infection for neglected populations: men who have sex with men. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  and Projections Working Group on Measuring Concurrent Modelling HIV: consensus indicators are needed for concurrency , 2010, The Lancet.

[6]  J. Kublin,et al.  Uptake of male circumcision in an HIV vaccine efficacy trial. , 2009, Journal of acquired immune deficiency syndromes.

[7]  D. Swendeman,et al.  The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. , 2009, Annual review of clinical psychology.

[8]  J. Vearey Migration, access to ART, and survivalist livelihood strategies in Johannesburg , 2008, African journal of AIDS research : AJAR.

[9]  D. Dickinson,et al.  Use and neglect of best-practice HIV/AIDS programme guides by South African companies , 2008, African journal of AIDS research : AJAR.

[10]  D. Dickinson Traditional healers, HIV/AIDS and company programmes in South Africa , 2008, African journal of AIDS research : AJAR.

[11]  C. Sprague Women's health, HIV/AIDS and the workplace in South Africa , 2008, African journal of AIDS research : AJAR.

[12]  M. Richter Sex work, reform initiatives and HIV/AIDS in inner-city Johannesburg , 2008, African journal of AIDS research : AJAR.

[13]  P. Aggleton,et al.  Structural approaches to HIV prevention , 2008, The Lancet.

[14]  T. Coates,et al.  Behavioural strategies to reduce HIV transmission: how to make them work better , 2008, The Lancet.

[15]  D. Serwadda,et al.  The history and challenge of HIV prevention , 2008, The Lancet.

[16]  J. Klausner,et al.  Reassessing HIV Prevention , 2008, Science.

[17]  South African Companies,et al.  The Definition and Utilisation of Best Practice HIV/AIDS Interventions in Large , 2007 .

[18]  H. Epstein,et al.  Why is HIV prevalence so severe in southern Africa? : the role of multiple concurrent partnerships and lack of male circumcision - implications for HIV prevention : opinion , 2007 .

[19]  L. Ellis The Impact of HIV/AIDS on Selected Business Sectors in South Africa , 2007 .

[20]  C. Watts,et al.  Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial , 2006, The Lancet.

[21]  D. Dickinson,et al.  Understanding the response of large South African companies to HIV/AIDS , 2005, SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance.

[22]  E. Kalipeni,et al.  A review of preventative efforts in the fight against HIV and AIDS in Africa , 2005 .

[23]  D. Dickinson Corporate South Africa's response to HIV/AIDS: Why so slow? , 2004 .

[24]  Lee Jong-wook Global health improvement and WHO: shaping the future , 2003, The Lancet.

[25]  D. Dickinson Managing HIV / AIDS in the South African workplace : just another duty? , 2003 .

[26]  G. Reid,et al.  Secrecy, stigma and HIV/AIDS: An introduction , 2003, African journal of AIDS research : AJAR.

[27]  Booncharoen Sirinaovakul,et al.  Introduction to the Special Issue , 2002, Comput. Intell..

[28]  Elizabeth Marum,et al.  Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century , 2002, The Lancet.

[29]  J. Mann The transformative potential of the HIV/AIDS pandemic , 1999 .

[30]  M. Berer Access to reproductive health: A question of distributive justice , 1999 .

[31]  D. Fleming,et al.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. , 1999, Sexually transmitted infections.

[32]  C. Prahalad Managing discontinuities : The emerging challenges , 1998 .

[33]  G. Herek,et al.  Public reactions to AIDS in the United States: a second decade of stigma. , 1993, American journal of public health.

[34]  J. Beinart Disease and Mortality in Sub-Saharan Africa , 1992 .

[35]  R. Feachem Disease and Mortality in Sub-Saharan Africa , 1991 .

[36]  J. Servais International Labour Organization (ILO) , 2011 .

[37]  Sixty-sixth,et al.  RESOLUTION ADOPTED BY THE GENERAL ASSEMBLY , 2011 .

[38]  L. Richey Changing the Course of AIDS: Peer Education in South Africa and Its Lessons for the Global Crisis , 2010 .

[39]  K. Cummings,et al.  The Past , Present , and Future of HIV Prevention : Integrating Behavioral , Biomedical , and Structural Intervention Strategies for the Next Generation of HIV Prevention , 2009 .

[40]  C. Beyrer,et al.  Public health aspects of HIV/AIDS in low and middle income countries: Epidemiology, prevention and care , 2009 .

[41]  A. Ehrhardt,et al.  Going beyond "ABC" to include "GEM": critical reflections on progress in the HIV/AIDS epidemic. , 2007, American journal of public health.

[42]  Treat Million by Initiative Treating 3 million by 2005. Making it happen: the WHO strategy. The WHO and UNAIDS global initiative to provide antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005 , 2003 .

[43]  G. Dallabetta,et al.  Workplace HIV / AIDS programs: an action guide for managers. , 2002 .

[44]  C. Simkins Can South Africa avoid a Malthusian positive check? , 2001, Daedalus.

[45]  S. Hewitt,et al.  HIV prevention through early detection and treatment of other sexually transmitted diseases--United States. Recommendations of the Advisory Committee for HIV and STD prevention. , 1998, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[46]  J. Kellison,et al.  And the band played on. , 1992, Geriatric nursing.

[47]  D. Halperin Why is HIV Prevalence so Severe in Southern Africa ? The role of multiple concurrent partnerships and lack of male circumcision : Implications for AIDS prevention , 2022 .